Based on initial studies, NRF2 was first considered a tumor suppressor gene, since a number of studies in other cancer types (i.e., colon, melanoma) and in mice showed that NFE2L2 deficiency increases the susceptibility to cancer [18,19,20]. This evidence concerns the gene NFE2L2 and cancer.